Lineage Therap(IL:LCTX)
ILA 312.00-34.60 (-9.98%)
IL:LCTX
Lineage Therap earnings date
ILA 312.00
At close:-34.60 (-9.98%)
Lineage Therap (LCTX) Q3 2022 Earnings Report
3 Followers
IL:LCTX Q3 2022 EPS Results
- Actual EPS
- -ILA 12.87
- Consensus EPS
- -ILA 11.26
- Beat/Miss
- Missed by -ILA 1.61
- One Year Ago EPS
- -ILA 16.08
IL:LCTX Q3 2022 Revenue Results
- Actual Revenue
- ILA 964.37M
- Expected Revenue
- ILA 1.25B
- Beat/Miss
- Missed by -ILA 289.18M
- YoY Revenue Growth
- +36.15%
Earnings Announcement Details
- Quarter
- Q3 2022
- Date
- 11/10/2022
- Time
- After Close
- Conference Call
- Thursday, November 10, 2022
IL:LCTX Upcoming Earnings
Lineage Therap's next earnings date is estimated for March 11, 2027, based on past reporting schedules.
Q3 2022 Earnings Call Audio
IL:LCTX Q3 2022 Earnings Call
0:00 / 0:00
Q3 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
IL:LCTX Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 11, 2027 | 2026 (Q4) | -7.40- | 1.29 | ― | ― |
| Nov 12, 2026 | 2026 (Q3) | -9.33-9.65 | -41.82 | 76.92% (+32.17) | |
| Aug 06, 2026 | 2026 (Q2) | -9.01-9.65 | -41.82 | 76.92% (+32.17) | |
| May 12, 2026 | 2026 (Q1) | -6.43-9.65 | -6.43 | -50.00% (-3.22) | |
| Mar 05, 2026 | 2025 (Q4) | -13.831.29 | -6.43 | 120.00% (+7.72) | |
| Nov 06, 2025 | 2025 (Q3) | -8.36-41.82 | -6.43 | -550.00% (-35.38) | |
| Aug 12, 2025 | 2025 (Q2) | -8.69-41.82 | -9.65 | -333.33% (-32.17) | |
| May 13, 2025 | 2025 (Q1) | -8.36-6.43 | -12.87 | 50.00% (+6.43) | |
| Mar 10, 2025 | 2024 (Q4) | -9.65-6.43 | -9.65 | 33.33% (+3.22) | |
| Nov 14, 2024 | 2024 (Q3) | -12.87-6.43 | -12.87 | 50.00% (+6.43) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
